Experts on the panel shared many of the same views around SSRIs, arguing that the risks of the drugs during pregnancy are greater than currently accepted.

There were warnings to the FDA about Sarepta Therapeutics Inc. before US regulators asked the company to halt shipments of its gene therapy.

The FDA's assessment of the bread recall has designated it as a Class II risk, which means the product "may cause temporary ...

The FDA has issued Class I recalls for chocolate products due to undeclared allergens and contamination—posing serious health ...